1. Home
  2. BLLN vs DAN Comparison

BLLN vs DAN Comparison

Compare BLLN & DAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BLLN

BillionToOne Inc.

N/A

Current Price

$73.45

Market Cap

3.9B

Sector

Health Care

ML Signal

N/A

Logo Dana Incorporated

DAN

Dana Incorporated

HOLD

Current Price

$36.03

Market Cap

3.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLLN
DAN
Founded
2016
1904
Country
United States
United States
Employees
713
N/A
Industry
Medical Specialities
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.3B
IPO Year
N/A
1998

Fundamental Metrics

Financial Performance
Metric
BLLN
DAN
Price
$73.45
$36.03
Analyst Decision
Buy
Buy
Analyst Count
7
5
Target Price
$126.71
$40.60
AVG Volume (30 Days)
380.2K
805.1K
Earning Date
05-06-2026
04-29-2026
Dividend Yield
N/A
1.28%
EPS Growth
N/A
264.10
EPS
N/A
0.64
Revenue
N/A
$7,500,000,000.00
Revenue This Year
$46.29
$1.89
Revenue Next Year
$30.14
$4.59
P/E Ratio
N/A
$58.66
Revenue Growth
N/A
N/A
52 Week Low
$61.96
$13.45
52 Week High
$138.70
$39.56

Technical Indicators

Market Signals
Indicator
BLLN
DAN
Relative Strength Index (RSI) 41.26 51.15
Support Level $64.99 $34.66
Resistance Level $83.20 $36.28
Average True Range (ATR) 6.48 1.21
MACD -1.05 -0.06
Stochastic Oscillator 9.57 28.67

Price Performance

Historical Comparison
BLLN
DAN

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About DAN Dana Incorporated

Dana Inc is engaged in the designing and manufacturing of efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company has four operating segments: Light Vehicles, Power Technologies, Commercial Vehicle, and Off-Highway. The Light Vehicles segment generates the majority portion of revenue by providing products to support light vehicle OEMs. Its products are designed for light trucks, SUVs, CUVs, vans, and passenger cars.

Share on Social Networks: